Ocean Biomedical, Inc.
NASDAQ:OCEA
0.9774 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||
| Net Income
| -14.087 | -13.028 | -67.401 | 0.41 | -1.018 | -7.333 | -5.375 | -8.178 | -4.886 | -5.341 | -43.939 | -0.885 | -0.012 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.186 | 0.186 | 0.646 | 0 | 2.934 | 4.901 | 4.543 | 4.543 | 4.543 | 4.543 | 42.921 | 0 | 0 |
| Change In Working Capital
| 1.58 | -1.426 | 1.927 | 0.471 | 1.056 | 2.165 | 0.191 | 3.493 | -0.256 | 0.603 | 0.901 | 0.865 | 0.012 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 1.539 | -1.263 | 1.445 | -1.924 | -0.142 | 0.08 | -0.996 | 0.03 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0.041 | -0.163 | 0.482 | 0.471 | 1.056 | 2.085 | 1.187 | 3.463 | -0.71 | 0 | 0 | 0 | 0 |
| Other Non Cash Items
| 11.191 | 9.486 | 62.177 | -1.025 | -0.352 | 0.115 | 0.274 | -0.002 | -0 | 0 | 0 | 0 | 0 |
| Operating Cash Flow
| -1.13 | -4.782 | -2.651 | -0.144 | -0.314 | -0.152 | -0.367 | -0.142 | -0.599 | -0.195 | -0.117 | -0.02 | 0 |
| Investing Activities: | |||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | -1.05 | -1.05 | 0 | 0 | 0 | -107.1 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | -1.05 | -1.05 | 0 | 0 | 0 | -107.1 | 0 | 0 | 0 | 0 |
| Financing Activities: | |||||||||||||
| Debt Repayment
| 0 | -1.55 | -0.55 | -1.05 | -1.05 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0 | 52.07 | 14.26 | 0 | 0.209 | -0.209 | 0 | 0 | 0.002 | 0.207 | 0.808 | 0 | 0 |
| Common Stock Repurchased
| -51.606 | 0 | -12.676 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0 | -43.883 | 1.889 | 0 | 0.137 | 0.255 | 0.599 | 0.042 | -0.003 | -0.037 | 0.094 | 0.02 | 0 |
| Financing Cash Flow
| 0 | 6.637 | 2.923 | 1.05 | 1.259 | 0.255 | 0.599 | 0.042 | -0.001 | 0.17 | 0.902 | 0.02 | 0 |
| Other Information: | |||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -1.13 | 1.855 | 0.272 | -0.144 | -0.105 | 0.103 | 0.232 | -0.1 | -0.6 | -0.025 | 0.785 | 0 | 0 |
| Cash At End Of Period
| 1.031 | 2.161 | 0.306 | 0.328 | 0.472 | 0.395 | 0.292 | 0.06 | 0.16 | 0.76 | 0.785 | 0 | 0 |